Page last updated: 2024-11-03

risperidone and Abortion, Spontaneous

risperidone has been researched along with Abortion, Spontaneous in 1 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Abortion, Spontaneous: Expulsion of the product of FERTILIZATION before completing the term of GESTATION and without deliberate interference.

Research Excerpts

ExcerptRelevanceReference
"To determine whether in utero exposure to the atypical antipsychotic risperidone is associated with poor pregnancy and fetal/neonatal outcomes."8.84Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes. ( Coppola, D; Kwarta, RF; Russo, LJ; Schmider, J; Varughese, R, 2007)
"To determine whether in utero exposure to the atypical antipsychotic risperidone is associated with poor pregnancy and fetal/neonatal outcomes."4.84Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes. ( Coppola, D; Kwarta, RF; Russo, LJ; Schmider, J; Varughese, R, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coppola, D1
Russo, LJ1
Kwarta, RF1
Varughese, R1
Schmider, J1

Reviews

1 review available for risperidone and Abortion, Spontaneous

ArticleYear
Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes.
    Drug safety, 2007, Volume: 30, Issue:3

    Topics: Abnormalities, Drug-Induced; Abortion, Induced; Abortion, Spontaneous; Adult; Antipsychotic Agents;

2007